The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury

Background:  Ventilator-associated pneumonia (VAP), or what the CDC recently renamed infection-related ventilator-associated complication (IVAC),  is defined as a nosocomial pneumonia occurring on day 3 of mechanical ventilation that was preceded …

NeurologyThoracic and Respiratory

Latest Posts

CRYOSTAT-2: Early Empiric Cryoprecipitate in Major Trauma

Pediatric UTIs: Short-Course vs. Standard-Course Antibiotics — Is It Time for a Change?

Rosh Review EM Scholar Monthly Question

Sponsored

In response to the ongoing global pandemic REBEL EM will be publishing our own thoughts and experiences treating COVID-19 patients.

Latest Posts

The RECOVERY Trial: Tocilizumab

BLAZE-1 Final Publication: Monoclonal Antibody Cocktail Part II

COVID-19 Awake Proning – All Hype?

No Evidence that REGN-COV2 (Regeneron) Antibody Cocktail Has Clinical Benefits

Useful infographics and charts free for use.

Latest Review

REBEL Review 107: D5, D10, & D20 Made Simple

Categories: Endocrine, Metabolic, Fluid, and Electrolytes

Recent Reviews

REBEL Review 106: Infant Wheezing – What Could It Be?

REBEL Review 105: Treatment of Ventricular Tachycardia

REBEL Review 104: IV Calcium

Sponsored